Prot #KB105-001: A Phase I/II Study of Topical KB105, a Replication-Incompetent, Non-Integrating HSV-1 Vector Expressing Human Transglutaminase 1 (TGM1) for the Treatment of TGM1-Deficient Autosomal Recessive Congenital Ichthyosis (ARCI)